• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories

tetano

Editor, Senior Moderator
Curr Opin Virol. 2014 Aug 7;8C:85-89. doi: 10.1016/j.coviro.2014.07.007. [Epub ahead of print]
Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.
Hensley SE.
Author information
Abstract

Seasonal influenza vaccine strains are routinely updated when influenza viruses acquire mutations in exposed regions of the hemagglutinin and neuraminidase glycoproteins. Ironically, although thousands of viral isolates are sequenced each year, today's influenza surveillance community places less emphasis on viral genetic information and more emphasis on classical serological assays when choosing vaccine strains. Here, I argue that these classical serological assays are oversimplified and that they fail to detect influenza mutations that facilitate escape of particular types of human antibodies. I propose that influenza vaccine strains should be updated more frequently even when classical serological assays fail to detect significant antigenic alterations.

Copyright ? 2014 Elsevier B.V. All rights reserved.

PMID:
25108824
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25108824
 
Back
Top Bottom